Prolactin ≤1 ng/mL Predicts Macroprolactinoma Reduction after Cabergoline Therapy.

CONCLUSIONS: A prolactin level ≤1 ng/mL at 3 months after cabergoline treatment was correlated with a significant tumor size reduction in patients with macroprolactinoma. This finding may help clinical decision-making when treating macroprolactinoma patients. PMID: 31770105 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31770105?dopt=Abstract

Source: European Journal of Endocrinology - October 31, 2019 Category: Endocrinology Authors: Kim D, Ku CR, Kim K, Jung H, Lee EJ Tags: Eur J Endocrinol Source Type: research

More News: Endocrinology | Hormones | MRI Scan | Study